Total Funding
5
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 5 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
454281
iPierian is a drug discovery platform that develops therapies for neurodegenerative diseases such as SMA, ALS, and Parkinson’s.
Acquired by 
Bristol-Myers Squibb
Nancy Stagliano: CEO, Board of DirectorsPast Role: True North Therapeutics, Co-Founder and CEO- George Daley: Co-FounderPast Role: Whitehead Institute for Biomedical Research, Whitehead Fellow
About the Company
We are using induced pluripotent stem cells for drug discovery and development. Focused on neurodegenerative diseases such as SMA, ALS and Parkinson's, and other major unmet medical needs.

